ETNB trade ideas

BADQOMOCAWGOWLD

NASDAQ:ETNB 89bio Inc Target PTs 29 --> 20 --> 43 and higher 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment...

Master_of_Fine_Charts

Price recently filled the gap at $5 and has since closed higher for 3 consecutive days creating a "3 white soldier" pattern. In addition the ADX displays a strong trend with a value of 39 with the D+ indicator rising. Targets: $6.46, $7.81

BullnBear_Markets

Just another chart with numbers looking good. My first TP as marked.

ZebulonDev

No financial advice, just an idea May be first target go to 28.

freddiegbruh

ETNB long, longer-term play 89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA. Pre-revenue, early stage company.

simers.co

Both its technical analysis and fundamental reports look great. This is a perfect time to buy this stock. TP 22.76

rcjugg

In oversold territory

simers.co

Both its technical analysis and fundamental reports look great. This is a perfect time to buy this stock.

Uncle_Abe_Options

This is a technical analysis . this stock is headed towards the $35 mark. watch it. This is not a signal. please trade are your own risk.

evnrandy

info from secform4.com july8th 275,000 shares bought at $27.5 $7,562,500 dollars worth 10% owner september 21rst 1,300,000 shares bought at $28 $36,400,000 dollars worth director 10% owner a few days after had bank of america upgrade from 37 to 43 dollars target posted on finviz.com in a long position up to around 43 dollars per share